96 related articles for article (PubMed ID: 20930084)
1. Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy.
Russwurm G; Heinsch M; Radkowski R; Erlemann R; Aul C; Haase S; Giagounidis A
Blood; 2010 Oct; 116(14):2617-8. PubMed ID: 20930084
[No Abstract] [Full Text] [Related]
2. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia.
Tecchio C; Nichele I; Todeschini G; Pizzolo G; Ambrosetti A
Br J Haematol; 2009 Jul; 146(2):222-3. PubMed ID: 19466973
[No Abstract] [Full Text] [Related]
3. Dasatinib induces a response in chronic lymphocytic leukemia.
Pitini V; Arrigo C; Altavilla G
Blood; 2009 Jan; 113(2):498. PubMed ID: 19131559
[No Abstract] [Full Text] [Related]
4. Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.
Nagao T; Takahashi N; Kameoka Y; Noguchi S; Shinohara Y; Ohyagi H; Kume M; Sawada K
Intern Med; 2013; 52(22):2567-71. PubMed ID: 24240798
[TBL] [Abstract][Full Text] [Related]
5. Activities of SYK and PLCgamma2 predict apoptotic response of CLL cells to SRC tyrosine kinase inhibitor dasatinib.
Song Z; Lu P; Furman RR; Leonard JP; Martin P; Tyrell L; Lee FY; Knowles DM; Coleman M; Wang YL
Clin Cancer Res; 2010 Jan; 16(2):587-99. PubMed ID: 20068106
[TBL] [Abstract][Full Text] [Related]
6. Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.
Zhou HS; Dai M; Wei Y; Wang Q; Xu N; Yin C; Meng F
Leuk Lymphoma; 2013 Jul; 54(7):1557-9. PubMed ID: 23194002
[No Abstract] [Full Text] [Related]
7. On the assessment of dasatinib-induced autophagy in CLL.
Krause G; Hallek M
Leuk Res; 2011 Jan; 35(1):137-8. PubMed ID: 20947165
[No Abstract] [Full Text] [Related]
8. The role of p53 and autophagy in Dasatinib resistance of CLL lymphocytes.
Pitini VV
Leuk Res; 2011 Jan; 35(1):32-3. PubMed ID: 20674019
[No Abstract] [Full Text] [Related]
9. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
[TBL] [Abstract][Full Text] [Related]
10. Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.
Crombet O; Lastrapes K; Zieske A; Morales-Arias J
Pediatr Blood Cancer; 2012 Aug; 59(2):333-4. PubMed ID: 22689211
[TBL] [Abstract][Full Text] [Related]
11. p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes.
Amrein L; Soulières D; Johnston JB; Aloyz R
Leuk Res; 2011 Jan; 35(1):99-102. PubMed ID: 20573397
[TBL] [Abstract][Full Text] [Related]
12. Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
Abdelhalim A; Barcos M; Block AW; Sait SN; Starostik P; Wetzler M; Wang ES
Leuk Lymphoma; 2007 May; 48(5):1053-6. PubMed ID: 17487757
[No Abstract] [Full Text] [Related]
13. The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes.
Veldurthy A; Patz M; Hagist S; Pallasch CP; Wendtner CM; Hallek M; Krause G
Blood; 2008 Aug; 112(4):1443-52. PubMed ID: 18550857
[TBL] [Abstract][Full Text] [Related]
14. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib.
Tucker DL; Mihailescu L; Riordan R; Rule S
Br J Haematol; 2017 Jul; 178(1):153-155. PubMed ID: 27172457
[No Abstract] [Full Text] [Related]
15. Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia.
Serpa M; Bendit I; Seguro F; Xavier F; Cavalcante M; Steinbaum D; Nardinelli L; Aldred VL; de Paula HM; Dorlhiac-Llacer PE
Acta Haematol; 2010; 124(2):105-9. PubMed ID: 20720403
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.
Christoforidou A; Kapsas G; Bezirgiannidou Z; Papamichos S; Kotsianidis Ι
Turk J Haematol; 2018 May; 35(2):147-149. PubMed ID: 29391330
[No Abstract] [Full Text] [Related]
17. Unsuccessful dasatinib therapy in a refractory patient with chronic lymphocytic leukemia.
Stagno F; Vigneri P; Del Fabro V; Fidilio A; Spina P; Massimino M; Messina A; Di Raimondo F
Acta Haematol; 2010; 124(2):103-4. PubMed ID: 20689270
[No Abstract] [Full Text] [Related]
18. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Foà R; Vitale A; Vignetti M; Meloni G; Guarini A; De Propris MS; Elia L; Paoloni F; Fazi P; Cimino G; Nobile F; Ferrara F; Castagnola C; Sica S; Leoni P; Zuffa E; Fozza C; Luppi M; Candoni A; Iacobucci I; Soverini S; Mandelli F; Martinelli G; Baccarani M;
Blood; 2011 Dec; 118(25):6521-8. PubMed ID: 21931113
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].
Zhu Y; Pan LQ; Qian SX; Song P; Yu H; Zhang SJ; Ge Z; Hong M; Tian T; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):581-6. PubMed ID: 23815902
[TBL] [Abstract][Full Text] [Related]
20. [Sustained remission with allogeneic peripheral blood stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic crisis of imatinib-resistant CML].
Narita T; Kayukawa S; Yoshida T; Kusumoto S; Kataoka T
Rinsho Ketsueki; 2013 Mar; 54(3):279-83. PubMed ID: 23676643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]